Runner this week (NYSE: ATNM) news out today - Actinium (NYSE: ATNM) is Advancing Twelve Products. Actinium has eight products currently in clinical trials. Institutional ownership on the rise.
Full report- https://mailchi.mp/broadstreetalerts/ready-fo...n-91454?e=[UNIQID]
(0)
(1)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links